Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements
Launched by UNIVERSITY OF SOUTHERN DENMARK · May 30, 2024
Trial Information
Current as of July 06, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best ways to treat complex shoulder fractures, specifically looking at two different approaches: non-surgical treatment and surgical treatment using different types of shoulder implants. The goal is to see which method leads to better recovery outcomes for patients with certain types of fractures in the upper arm bone near the shoulder. While older patients often receive non-surgical treatment, many do not have satisfactory results, so the researchers want to explore whether surgical options, particularly reverse shoulder arthroplasty, can provide better results.
To be eligible for this trial, participants should have a specific type of shoulder fracture known as a displaced proximal humeral fracture. This means the bone is broken in a way that has shifted its position. Patients who have other types of fractures, certain complications, or who are not able to comply with the study rules may not be included. Those who participate can expect to be part of a comparison between the two treatment methods and the different implant designs. It's important to note that this trial is currently not recruiting new participants, meaning they are not looking for new volunteers at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Displaced Proximal Humeral Fractures (PHF) Neer type III or IV / AO B\&C. Radiological confirmed
- Exclusion Criteria:
- • other types of PHF, Head splits, gleno-humeral dislocations, pathological fractures. Refuse to participate in the study. Non-compliant, drug/alcohol abuse or institutionalized, (Low-cooperative),
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Esbjerg, South, Denmark
Patients applied
Trial Officials
Klaus Hanisch
Study Chair
University of Southern Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported